These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19409081)

  • 1. WISDOM-II: screening against multiple targets implicated in malaria using computational grid infrastructures.
    Kasam V; Salzemann J; Botha M; Dacosta A; Degliesposti G; Isea R; Kim D; Maass A; Kenyon C; Rastelli G; Hofmann-Apitius M; Breton V
    Malar J; 2009 May; 8():88. PubMed ID: 19409081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
    J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grid enabled high throughput virtual screening against four different targets implicated in malaria.
    Salzemann J; Kasam V; Jacq N; Maass A; Schwichtenberg H; Breton V
    Stud Health Technol Inform; 2007; 126():47-54. PubMed ID: 17476047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of in silico docking at a large scale on grid infrastructure.
    Jacq N; Salzemann J; Legre Y; Reichstadt M; Jacq F; Zimmermann M; Maass A; Sridhar M; Vinod-Kusam K; Schwichtenberg H; Hofmann M; Breton V
    Stud Health Technol Inform; 2006; 120():155-7. PubMed ID: 16823133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico drug discovery approaches on grid computing infrastructures.
    Wolf A; Shahid M; Kasam V; Ziegler W; Hofmann-Apitius M
    Curr Clin Pharmacol; 2010 Feb; 5(1):37-46. PubMed ID: 19642967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and discovery of plasmepsin II inhibitors using an automated workflow on large-scale grids.
    Degliesposti G; Kasam V; Da Costa A; Kang HK; Kim N; Kim DW; Breton V; Kim D; Rastelli G
    ChemMedChem; 2009 Jul; 4(7):1164-73. PubMed ID: 19437467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicomplex-based pharmacophore modeling in conjunction with multi-target docking and molecular dynamics simulations for the identification of
    Manhas A; Lone MY; Jha PC
    J Biomol Struct Dyn; 2019 Oct; 37(16):4181-4199. PubMed ID: 30648473
    [No Abstract]   [Full Text] [Related]  

  • 11. Phthalide derivatives as dihydrofolate reductase inhibitors for malaria: molecular docking and molecular dynamics studies.
    Ibraheem W; Makki AA; Alzain AA
    J Biomol Struct Dyn; 2023 Jul; 41(11):5127-5137. PubMed ID: 35635144
    [No Abstract]   [Full Text] [Related]  

  • 12. New paradigm of an old target: an update on structural biology and current progress in drug design towards plasmepsin II.
    Dan N; Bhakat S
    Eur J Med Chem; 2015 May; 95():324-48. PubMed ID: 25827401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grid-added value to address malaria.
    Breton V; Jacq N; Kasam V; Hofmann-Apitius M
    IEEE Trans Inf Technol Biomed; 2008 Mar; 12(2):173-81. PubMed ID: 18348947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Traditional Chinese Medicine Derived Compounds as Wild Type and Mutant Plasmodium falciparum Dihydrofolate Reductase Inhibitors: Induced Fit Docking and ADME Studies.
    Iwaloye O; Elekofehinti OO; Kikiowo B; Fadipe TM; Akinjiyan MO; Ariyo EO; Aiyeku OO; Adewumi NA
    Curr Drug Discov Technol; 2021; 18(4):554-569. PubMed ID: 32729419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shape- and chemical feature-based 3D-pharmacophore model generation and virtual screening: identification of potential leads for P. falciparum DHFR enzyme inhibition.
    Adane L; Patel DS; Bharatam PV
    Chem Biol Drug Des; 2010 Jan; 75(1):115-26. PubMed ID: 19895504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Selective Inhibitors of
    Sharma VK; Bharatam PV
    J Comput Biol; 2021 Jan; 28(1):43-59. PubMed ID: 32207987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oplodiol and nitidine as potential inhibitors of
    Akakpo L; Gasu EN; Mensah JO; Borquaye LS
    J Biomol Struct Dyn; 2024; 42(4):1655-1669. PubMed ID: 37194452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
    Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK
    J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origins of the specificity of inhibitor P218 toward wild-type and mutant PfDHFR: a molecular dynamics analysis.
    Abbat S; Jain V; Bharatam PV
    J Biomol Struct Dyn; 2015 Sep; 33(9):1913-28. PubMed ID: 25333695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.